The global nucleic acid methylation market size is calculated at USD 3.97 billion in 2025 and is forecasted to reach around USD 13.66 billion by 2034, accelerating at a CAGR of 14.72% from 2025 to 2034. The North America market size surpassed USD 1.42 billion in 2024 and is expanding at a CAGR of 14.85% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Nucleic Acid Methylation Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Nucleic Acid Methylation Market Revenue and Volume, by Product & Services
8.1.1. Kits & Reagents
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Enzymes
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Services
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. Instruments & Software
8.1.4.1. Market Revenue and Volume Forecast
8.1.5. Consumables
8.1.5.1. Market Revenue and Volume Forecast
9.1. Nucleic Acid Methylation Market Revenue and Volume, by Type
9.1.1. DNA Methylation
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. RNA Methylation
9.1.2.1. Market Revenue and Volume Forecast
10.1. Nucleic Acid Methylation Market Revenue and Volume, by Technology
10.1.1. Next-Generation Sequencing (NGS)
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Bisulfite Sequencing & PCR-based Techniques
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Microarray-based Methylation Analysis
10.1.3.1. Market Revenue and Volume Forecast
10.1.4. Mass Spectrometry
10.1.4.1. Market Revenue and Volume Forecast
10.1.5. Hybridization-based & Antibody-based Detection
10.1.5.1. Market Revenue and Volume Forecast
11.1. Nucleic Acid Methylation Market Revenue and Volume, by Application
11.1.1. Drug Discovery & Personalized Medicines
11.1.1.1. Market Revenue and Volume Forecast
11.1.2. Clinical Diagnostics
11.1.2.1. Market Revenue and Volume Forecast
11.1.3. Others
11.1.3.1. Market Revenue and Volume Forecast
12.1. Nucleic Acid Methylation Market Revenue and Volume, by End-use
12.1.1. Pharmaceutical & Biotechnology Companies
12.1.1.1. Market Revenue and Volume Forecast
12.1.2. Academic & Research Institutes
12.1.2.1. Market Revenue and Volume Forecast
12.1.3. Hospitals & Diagnostic Laboratories
12.1.3.1. Market Revenue and Volume Forecast
13.1. North America
13.1.1. Market Revenue and Volume Forecast, by Product & Services
13.1.2. Market Revenue and Volume Forecast, by Type
13.1.3. Market Revenue and Volume Forecast, by Technology
13.1.4. Market Revenue and Volume Forecast, by Application
13.1.5. Market Revenue and Volume Forecast, by End-use
13.1.6. U.S.
13.1.6.1. Market Revenue and Volume Forecast, by Product & Services
13.1.6.2. Market Revenue and Volume Forecast, by Type
13.1.6.3. Market Revenue and Volume Forecast, by Technology
13.1.6.4. Market Revenue and Volume Forecast, by Application
13.1.6.5. Market Revenue and Volume Forecast, by End-use
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Volume Forecast, by Product & Services
13.1.7.2. Market Revenue and Volume Forecast, by Type
13.1.7.3. Market Revenue and Volume Forecast, by Technology
13.1.7.4. Market Revenue and Volume Forecast, by Application
13.1.7.5. Market Revenue and Volume Forecast, by End-use
13.2. Europe
13.2.1. Market Revenue and Volume Forecast, by Product & Services
13.2.2. Market Revenue and Volume Forecast, by Type
13.2.3. Market Revenue and Volume Forecast, by Technology
13.2.4. Market Revenue and Volume Forecast, by Application
13.2.5. Market Revenue and Volume Forecast, by End-use
13.2.6. UK
13.2.6.1. Market Revenue and Volume Forecast, by Product & Services
13.2.6.2. Market Revenue and Volume Forecast, by Type
13.2.6.3. Market Revenue and Volume Forecast, by Technology
13.2.7. Market Revenue and Volume Forecast, by Application
13.2.8. Market Revenue and Volume Forecast, by End-use
13.2.9. Germany
13.2.9.1. Market Revenue and Volume Forecast, by Product & Services
13.2.9.2. Market Revenue and Volume Forecast, by Type
13.2.9.3. Market Revenue and Volume Forecast, by Technology
13.2.10. Market Revenue and Volume Forecast, by Application
13.2.11. Market Revenue and Volume Forecast, by End-use
13.2.12. France
13.2.12.1. Market Revenue and Volume Forecast, by Product & Services
13.2.12.2. Market Revenue and Volume Forecast, by Type
13.2.12.3. Market Revenue and Volume Forecast, by Technology
13.2.12.4. Market Revenue and Volume Forecast, by Application
13.2.13. Market Revenue and Volume Forecast, by End-use
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Volume Forecast, by Product & Services
13.2.14.2. Market Revenue and Volume Forecast, by Type
13.2.14.3. Market Revenue and Volume Forecast, by Technology
13.2.14.4. Market Revenue and Volume Forecast, by Application
13.2.15. Market Revenue and Volume Forecast, by End-use
13.3. APAC
13.3.1. Market Revenue and Volume Forecast, by Product & Services
13.3.2. Market Revenue and Volume Forecast, by Type
13.3.3. Market Revenue and Volume Forecast, by Technology
13.3.4. Market Revenue and Volume Forecast, by Application
13.3.5. Market Revenue and Volume Forecast, by End-use
13.3.6. India
13.3.6.1. Market Revenue and Volume Forecast, by Product & Services
13.3.6.2. Market Revenue and Volume Forecast, by Type
13.3.6.3. Market Revenue and Volume Forecast, by Technology
13.3.6.4. Market Revenue and Volume Forecast, by Application
13.3.7. Market Revenue and Volume Forecast, by End-use
13.3.8. China
13.3.8.1. Market Revenue and Volume Forecast, by Product & Services
13.3.8.2. Market Revenue and Volume Forecast, by Type
13.3.8.3. Market Revenue and Volume Forecast, by Technology
13.3.8.4. Market Revenue and Volume Forecast, by Application
13.3.9. Market Revenue and Volume Forecast, by End-use
13.3.10. Japan
13.3.10.1. Market Revenue and Volume Forecast, by Product & Services
13.3.10.2. Market Revenue and Volume Forecast, by Type
13.3.10.3. Market Revenue and Volume Forecast, by Technology
13.3.10.4. Market Revenue and Volume Forecast, by Application
13.3.10.5. Market Revenue and Volume Forecast, by End-use
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Volume Forecast, by Product & Services
13.3.11.2. Market Revenue and Volume Forecast, by Type
13.3.11.3. Market Revenue and Volume Forecast, by Technology
13.3.11.4. Market Revenue and Volume Forecast, by Application
13.3.11.5. Market Revenue and Volume Forecast, by End-use
13.4. MEA
13.4.1. Market Revenue and Volume Forecast, by Product & Services
13.4.2. Market Revenue and Volume Forecast, by Type
13.4.3. Market Revenue and Volume Forecast, by Technology
13.4.4. Market Revenue and Volume Forecast, by Application
13.4.5. Market Revenue and Volume Forecast, by End-use
13.4.6. GCC
13.4.6.1. Market Revenue and Volume Forecast, by Product & Services
13.4.6.2. Market Revenue and Volume Forecast, by Type
13.4.6.3. Market Revenue and Volume Forecast, by Technology
13.4.6.4. Market Revenue and Volume Forecast, by Application
13.4.7. Market Revenue and Volume Forecast, by End-use
13.4.8. North Africa
13.4.8.1. Market Revenue and Volume Forecast, by Product & Services
13.4.8.2. Market Revenue and Volume Forecast, by Type
13.4.8.3. Market Revenue and Volume Forecast, by Technology
13.4.8.4. Market Revenue and Volume Forecast, by Application
13.4.9. Market Revenue and Volume Forecast, by End-use
13.4.10. South Africa
13.4.10.1. Market Revenue and Volume Forecast, by Product & Services
13.4.10.2. Market Revenue and Volume Forecast, by Type
13.4.10.3. Market Revenue and Volume Forecast, by Technology
13.4.10.4. Market Revenue and Volume Forecast, by Application
13.4.10.5. Market Revenue and Volume Forecast, by End-use
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Volume Forecast, by Product & Services
13.4.11.2. Market Revenue and Volume Forecast, by Type
13.4.11.3. Market Revenue and Volume Forecast, by Technology
13.4.11.4. Market Revenue and Volume Forecast, by Application
13.4.11.5. Market Revenue and Volume Forecast, by End-use
13.5. Latin America
13.5.1. Market Revenue and Volume Forecast, by Product & Services
13.5.2. Market Revenue and Volume Forecast, by Type
13.5.3. Market Revenue and Volume Forecast, by Technology
13.5.4. Market Revenue and Volume Forecast, by Application
13.5.5. Market Revenue and Volume Forecast, by End-use
13.5.6. Brazil
13.5.6.1. Market Revenue and Volume Forecast, by Product & Services
13.5.6.2. Market Revenue and Volume Forecast, by Type
13.5.6.3. Market Revenue and Volume Forecast, by Technology
13.5.6.4. Market Revenue and Volume Forecast, by Application
13.5.7. Market Revenue and Volume Forecast, by End-use
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Volume Forecast, by Product & Services
13.5.8.2. Market Revenue and Volume Forecast, by Type
13.5.8.3. Market Revenue and Volume Forecast, by Technology
13.5.8.4. Market Revenue and Volume Forecast, by Application
13.5.8.5. Market Revenue and Volume Forecast, by End-use
14.1. New England Biolabs
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Thermo Fisher Scientific Inc.
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Illumina Inc.
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Abcam plc
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. F. Hoffmann-La Roche Ltd
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Agilent Technologies Inc.
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Bio-Rad Laboratories, Inc.
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. QIAGEN
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Exact Sciences Corporation
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Diagenode Diagnostics S.A.
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client